» Articles » PMID: 30880636

Muscle Performance and Postural Stability Are Reduced in Patients with Newly Diagnosed Graves' Disease

Overview
Journal Thyroid
Date 2019 Mar 19
PMID 30880636
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Reduced muscle strength is an acknowledged symptom of Graves' disease, but the knowledge on severity is sparse. This study aimed to investigate muscle strength, balance, and muscle function in patients with Graves' disease compared to age- and sex-matched healthy controls. Using a cross-sectional design, 55 patients newly diagnosed with Graves' disease were compared to 55 euthyroid controls, matched on sex, age, and menopausal status. Isometric muscle strength (N) and maximum force production (N/s) were measured across different muscles groups using a dynamometer chair and postural stability (balance) in different positions using a stadiometer. Muscle function was assessed using the Timed-Up-and-Go test and the Repeated Chair Stand test. Patients and controls were well matched. Handgrip maximum muscle strength as well as strength at elbow and knee flexion and extension were significantly impaired in patients compared to controls. Maximum force production was only significantly reduced at elbow flexion. Patients performed the Timed-Up-and-Go and the Repeated Chair Stand test significantly slower than controls, and postural stability was significantly reduced in patients compared to controls in all positions. Free triiodothyronine correlated with reduced muscle strength and postural stability. At the time of diagnosis, Graves' disease is associated with impaired maximum muscle strength, performance, and balance, whereas maximum force production is overall comparable to euthyroid controls.

Citing Articles

Evaluation of the Dysregulation of Cholesterol and Glucose Levels in Graves' Disease Using Clinical Data Analysis.

Kareem Z, Al-Kazazz F, Rheima A, Sultan A Rep Biochem Mol Biol. 2025; 13(2):159-166.

PMID: 39995640 PMC: 11847589. DOI: 10.61186/rbmb.13.2.159.


Aberrant expression of thyroidal hormone receptor α exasperating mitochondrial dysfunction induced sarcopenia in aged mice.

Sheng Y, Zhu X, Wei L, Zou Y, Qi X, Shi R Aging (Albany NY). 2024; 16(8):7141-7152.

PMID: 38643465 PMC: 11087121. DOI: 10.18632/aging.205748.


Ultrasound measurement of vastus lateralis and vastus medialis muscle parameters to identify chronic thyrotoxic myopathy.

Fu S, Wang R, Liang X, Xian J, Pan J, Chen X Endocr Connect. 2023; 12(11).

PMID: 37682119 PMC: 10563633. DOI: 10.1530/EC-23-0083.


Immunometabolic signatures predict recovery from thyrotoxic myopathy in patients with Graves' disease.

Setoyama D, Lee H, Moon J, Tian J, Kang Y, Lee J J Cachexia Sarcopenia Muscle. 2021; 13(1):355-367.

PMID: 34970859 PMC: 8818593. DOI: 10.1002/jcsm.12889.


Levothyroxine Therapy in Elderly Patients With Hypothyroidism.

Effraimidis G, Watt T, Feldt-Rasmussen U Front Endocrinol (Lausanne). 2021; 12:641560.

PMID: 33790867 PMC: 8006441. DOI: 10.3389/fendo.2021.641560.